RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:60% of the road = 270-daysGreat post CS. Your last line re: aerosols is thought provoking..yes it does seem that bigPharma are overlooking the fact that our airways are our line of first defense!!
Cancerslayer wrote:
Nice post Eoganacht...
I always have to keep my eye on the forest for the trees when discussing TLT's transcending/versatile ACT & its value. You could probably count on one hand the number of drugs/treatments under study (globally) that have the realistic potential to "effectively" & "safely" treat both a variety of infectious diseases as well as a variety of cancers. Our ACT is truly on the verge of distinguishing itself as a one-of-a-kind tech that epitomizes translational research/medicine imo. Of course, none of our NMIBC competitors can come close to saying the same....And TLT's potential only escalates when you consider it's tech working in concert with other therapies when needed. Whether we hit, exceed or fall under that 40% mark, the likelihood we discover so much more hidden value beyond treating bladder cancer is more than strong imo. Good luck....
P.S. Still hoping TLT takes a serious look at the potential of using an aerosolized intranasal/inhalation approach for their Covid vaccine...the airway is our first line of defense & it seems many Pharmas are overlooking this important fact.
[/quote]